Tag: Dentistry Excellence Award

Ahmed A Holiel | Dentistry | Research Excellence Award

Published on by WSA Awards

Assist. Prof. Dr. Ahmed A Holiel | Dentistry | Research Excellence Award

Alexandria University, Beirut Arab University | Egypt

Assist. Prof. Dr. Ahmed A. Holiel is an accomplished academic and clinician specializing in Restorative and Esthetic Dentistry, with a core research focus on biomaterials, pulp regeneration, digital dentistry, and adhesive restorative systems. He earned his Bachelor’s degree with honors from the Faculty of Dentistry, Alexandria University, followed by a Master’s and Ph.D. in Restorative & Esthetic Dentistry from the same institution. Notably, he became the first researcher at Alexandria University’s Faculty of Dentistry to be exempted from Ph.D. thesis defense after publishing two articles in top-tier ISI journals. Dr. Holiel has progressed through a solid academic career pathway, beginning as a Demonstrator and later assuming roles as Assistant Lecturer and Lecturer at Alexandria University. He currently serves as an Assistant Professor of Restorative & Esthetic Dentistry at Beirut Arab University, Lebanon. He has also contributed internationally as a visiting lecturer at multiple institutions, including the Arab Academy for Science, Technology & Maritime Transport. His contributions to research are significant, with numerous peer-reviewed publications in well-recognized journals covering tissue engineering, biomimetic materials, laser dentistry, pulp regeneration, and emerging technologies in dental science. His work includes multiple clinical trials, in vitro studies, systematic reviews, meta-analyses, and innovation-driven translational research. He also serves as a peer reviewer for leading scholarly journals and acts as Guest and Lead Editor for notable international journals, demonstrating his expertise and academic leadership. Dr. Holiel’s teaching portfolio includes undergraduate, postgraduate, and international credit-hour programs, with roles as course director and coordinator in various operative and esthetic dentistry modules. His clinical experience extends to digital workflows, CAD/CAM systems, smile design, and laser-assisted restorative procedures. A recipient of several distinctions, including the Egyptian Hatton Award and multiple institutional recognitions, Dr. Holiel is an active member of global professional bodies such as the International Association for Dental Research (IADR) and the Tissue Engineering and Regenerative Medicine Society.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Grawish, M. E., Grawish, L. M., Grawish, H. M., Grawish, M. M., Holiel, A. A., Sultan, N., … (2022). Demineralized dentin matrix for dental and alveolar bone tissues regeneration: An innovative scope review. Tissue Engineering and Regenerative Medicine, 19(4), 687–701.

Holiel, A. A., Mahmoud, E. M., Abdel-Fattah, W. M., & Kawana, K. Y. (2021). Histological evaluation of the regenerative potential of a novel treated dentin matrix hydrogel in direct pulp capping. Clinical Oral Investigations, 25(4), 2101–2112.

Holiel, A. A., Mahmoud, E. M., & Abdel-Fattah, W. M. (2021). Tomographic evaluation of direct pulp capping using a novel injectable treated dentin matrix hydrogel: A 2-year randomized controlled clinical trial. Clinical Oral Investigations, 25(7), 4621–4634.

Morsy, N., & Holiel, A. A. (2023). Color difference for shade determination with visual and instrumental methods: A systematic review and meta-analysis. Systematic Reviews, 12(1), 95.

Abbassy, K. M., Elmahy, W. A., & Holiel, A. A. (2023). Evaluation of the proximal contact tightness in class II resin composite restorations using different contact forming instruments: A 1-year randomized controlled clinical trial. BMC Oral Health, 23(1), 729.

Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Published on by WSA Awards

Assoc. Prof. Dr. Hsien-Hao Huang | Medicine and Dentistry | Excellence in Research Award

Institute of Emergency and Critical Care Medicine | Taiwan

Dr. Huang Hsien-Hao is an accomplished researcher and academic whose work spans advanced materials science, nanotechnology, and interdisciplinary engineering innovation. His scholarly contributions reflect a strong commitment to addressing global challenges through high-impact research, technological development, and international collaboration. Over the course of his career, Dr. Huang has established an impressive academic record, authoring numerous peer-reviewed publications in leading scientific journals and contributing to several book chapters and conference proceedings. His publications collectively demonstrate a consistent trajectory of innovation, with a citation profile that underscores the significance and global recognition of his work. Dr. Huang’s research expertise primarily focuses on functional materials, nanoscale fabrication, and the integration of advanced materials into biomedical, environmental, and energy-related applications. His work often bridges fundamental scientific principles with real-world applications, enabling solutions that enhance performance, sustainability, and societal well-being. Through his leadership in multidisciplinary projects, Dr. Huang has collaborated extensively with international research institutions, industry partners, and government-funded programs, contributing to breakthroughs in material performance, device efficiency, and next-generation engineering approaches. In recognition of his research excellence, Dr. Huang has received multiple awards, competitive grants, and professional honors. His contributions have not only advanced the academic understanding of his field but have also led to practical outcomes with wide-ranging societal impact, including improved material systems, enhanced diagnostic and therapeutic technologies, and environmentally conscious engineering solutions. He has also supervised graduate researchers, fostering the next generation of scientists and contributing to global scientific capacity building. Dr. Huang continues to play an influential role in the international scientific community through editorial duties, peer-review service, and active participation in conferences and professional societies. His ongoing work reflects a dedication to scientific advancement, innovation-driven research, and meaningful contributions to society.

Profiles: Scopus | ORCID

Featured Publications

  1. Predicting high-risk return at emergency department presentation for patients who undergo short-term revisits: The HANDLE-24 score. (2025). BMC Emergency Medicine.
  2. Association between intrinsic capacity and hospital admission among older adults in the emergency department. (2025). Journal of Applied Gerontology.
  3. Risk factors for mortality among patients with splenic infarction in the emergency department. (2025). Journal of the Formosan Medical Association.
  4. Sarcopenia-related changes in serum GLP-1 level affect myogenic differentiation. (2024). Journal of Cachexia, Sarcopenia and Muscle.
  5. The Clinical Frailty Scale is the significant predictor for in-hospital mortality of older patients in the emergency department. (2024). Letter.

 

Maria Sundvall | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Maria Sundvall | Medicine and Dentistry | Best Researcher Award

University of Turku, Finland

Dr. Maria Sundvall is a distinguished physician-scientist and academic leader in Clinical Oncology and Molecular Cancer Biology, renowned for her translational research bridging laboratory discoveries with clinical applications. She earned her Medical Doctor degree in 2003, followed by a Ph.D. in Medical Biochemistry and Molecular Biology from the University of Turku, Finland, in 2007, where her thesis focused on “Signaling of ErbB4 Isoforms in Cancer.” She was later awarded the Title of Docent in 2015 and became a Specialist Physician in Clinical Oncology and Radiotherapy in 2018. Professionally, Dr. Sundvall serves as a Consultant in Clinical Oncology at Turku University Hospital and a Clinical Lecturer at the Institute of Biomedicine, University of Turku, where she also directs the Cancer Research Unit. Her earlier career includes postdoctoral research at Harvard Medical School under Professor P.P. Pandolfi, where she advanced her expertise in oncogenic signaling and targeted cancer therapies. Her research interests focus on receptor tyrosine kinase signaling, metabolic vulnerabilities in cancer, resistance mechanisms to EGFR-targeting therapies, and precision oncology for breast and prostate cancers. Dr. Sundvall possesses advanced research skills in molecular biology, cell signaling, cancer genomics, and translational medicine, with proficiency in various laboratory and clinical trial methodologies. She has authored over 34 publications in prestigious journals such as PNAS, Cancer Research, Clinical Cancer Research, and Oncogene, contributing key insights into cancer mechanisms and therapeutic resistance. Her numerous honors include the Turku University Foundation Ph.D. Thesis Award and research grants exceeding €1 million from the Research Council of Finland, the Finnish Medical Foundation, and the Sigrid Juselius Foundation. In conclusion, Dr. Sundvall exemplifies excellence in research, teaching, and clinical innovation, with her work significantly advancing the understanding of cancer biology and influencing future directions in precision oncology and patient-centered cancer care worldwide.

Profiles: Scopus | ORCID | LinkedIn

Featured Publications

Sriraman, S., Virtanen, V., Kukkula, A., Toriseva, M., Lumiainen, A., West, G., Poutanen, M., Taimen, P., & Sundvall, M. (2025). Androgen receptor‐mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer. The Journal of Pathology. Advance online publication.

Koskela, S., Pulkkinen, O., Mehmood, A., Kallionpää, R., Birkman, E.-M., Huuhtanen, J., Mustjoki, S., Coupland, S., Aittokallio, T., & Sundvall, M. (2025, July 8). Novel anti-PD1 predictive signature and functional dendritic-cell biomarkers in melanoma identified with systems immunology [Preprint]. Research Square.

Gnjatovic, J., Garces Ibanez, J., Rantala, J., Sundvall, M., Alanne, E., Vaittinen, S., Mattila, P., Jäättelä, M., & Hämälistö, S. (2025, April 29). Patient-derived lymphoma organoids and repurposed drugs: Novel solutions for improved B cell lymphoma treatment [Conference paper].

Hollmén, M., Löyttyniemi, E., Juhanoja, E., Vihinen, P., & Sundvall, M. (2025, February). High comorbidity and tumor proliferation predict survival of localized breast cancer patients after curative surgery: A retrospective analysis of real-world data in Finland. Surgical Oncology, 102(188).

Nissi, L., Tuominen, S., Routila, J., Huusko, T., Ketonen, P., Sundvall, M., Leivo, I., Irjala, H., Minn, H., & Grönroos, T. J. (2024, November). xCT as a predictor for survival in a population‐based cohort of head and neck squamous cell carcinoma. Cancer Medicine.

Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Assoc. Prof. Dr. Waseem AlZamzami | Medicine and Dentistry | Best Researcher Award

University of Tabuk, Saudi Arabia

Assoc. Prof. Dr. Waseem A. AlZamzami is an accomplished researcher and academic in hematopathology, molecular hematology, and cancer biology, with a strong focus on genomics, transcriptomics, metabolomics, and bioinformatics. He earned his Ph.D. in Clinical Laboratory Science from The Catholic University of America, Washington DC (2015–2022), following an M.S. in Health Sciences from Quinnipiac University, Connecticut (2013–2015), and a B.Sc. in Laboratory Medicine from Umm Al-Qurra University, Saudi Arabia (2002–2006). His professional journey includes extensive research training at the National Cancer Institute/National Institutes of Health (NCI/NIH), Bethesda, USA, where he contributed to advancing cancer genetics and translational hematology. Currently serving as an Assistant Professor of Hematology at the University of Tabuk, Saudi Arabia, he has held multiple leadership roles such as Committee Chairman for Laboratory Management, Unit Chairman for Measurement and Evaluation, and active member of Accreditation, Quality Assurance, and Curriculum Development committees. His research interests center on genetic screening, biomarker discovery, and integration of multi-omics to drive precision oncology and personalized treatment strategies. Dr. AlZamzami has authored publications in reputed journals including Discovery Medicine, Molecular Syndromology, PLOS ONE, and Cancers, with a Scopus record of 9 documents, 36 citations, and an h-index of 3, alongside three recent Saudi patents in hematological malignancies and cancer genomics. He is also a dedicated reviewer for journals such as PLOS ONE, Process Biochemistry, and International Immunopharmacology. His research skills span molecular diagnostics, bioinformatics, laboratory medicine, multi-omics analysis, and translational applications bridging bench to bedside. Recognized through international symposium presentations at NIH and national scientific forums, he has also contributed to scientific community development by mentoring students and organizing academic events. In conclusion, Dr. Waseem A. AlZamzami exemplifies a distinguished researcher whose academic excellence, innovative research, and leadership contributions to cancer biology and hematology strongly position him as a driving force in advancing precision medicine and biomedical research globally.

Profile: Scopus |ORCID| Google Scholar

Featured Publications

  1. Yan, H., Malik, N., Kim, Y. I., He, Y., Li, M., Dubois, W., Liu, H., Peat, T. J., Nguyen, J. T., … (2021). Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. EMBO Reports, 22(6), e52122.

  2. Oyouni, A. A. A., Al-Amer, O. M., Ali, F. A. Z., Altayar, M. A., Jalal, M. M., Albalawi, R. S. M., … (2022). Melatonin ameliorates the adrenal and pancreatic alterations in streptozotocin-induced diabetic rats: Clinical, biochemical, and descriptive histopathological studies. Frontiers in Veterinary Science, 9, 1016312.

  3. Seshadri, V. D., Oyouni, A. A. A., Hawsawi, Y. M., Aljohani, S. A. S., Al-Amer, O. M., … (2022). Chemopreventive role of Tin oxide–Chitosan–Polyethylene glycol–Crocin nanocomposites against lung cancer: An in vitro and in vivo approach. Process Biochemistry, 120, 186–194.

  4. Al-Amer, O. M., Mir, R., Hamadi, A., Alasseiri, M. I., Altayar, M. A., AlZamzami, W., … (2023). Antiapoptotic gene genotype and allele variations and the risk of lymphoma. Cancers, 15(4), 1012.

  5. Vijayaragavan, P., Rathi, M. A., Gopalakrishnan, V. K., Pashameah, R. A., … (2022). CpG methylation analysis of tumour suppressor gene and expression of cathepsin B in renal cell carcinoma. Journal of King Saud University – Science, 34(8), 102330.

Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Published on by WSA Awards

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

HYO-SANG PARK | Dentistry | Excellence in Research Award

Published on by WSA Awards

Prof. HYO-SANG PARK | Dentistry | Excellence in Research Award

Department of Orthodontics, Kyungpook National Univsersity, South Korea

Prof. Hyo-Sang Park, DDS, MSD, Ph.D., is a distinguished scholar, clinician, and global leader in orthodontics, widely recognized for pioneering orthodontic microimplants that have revolutionized treatment protocols worldwide. He completed his Doctor of Dental Surgery (DDS) at Kyungpook National University in Daegu, Korea, followed by specialist orthodontic training and authorization at Kyungpook National University Hospital. He earned a Master of Science in Orthodontics and later obtained his Ph.D. in Oral Biology and Orthodontics from Kyungpook National University, reflecting a solid academic foundation. Professionally, he has served as a full-time instructor, assistant professor, and associate professor at Keimyung University Medical College before becoming Professor and Chair of the Department of Orthodontics at Kyungpook National University, while also enriching his international exposure as a Visiting Associate Professor at the University of Oklahoma, USA. His research interests include the development of orthodontic microimplants, microimplant-assisted orthodontic treatment, clear aligner-microimplant combined treatment, and orthognathic surgery. With expertise spanning biomechanics, surgical orthodontics, device design, and clinical applications, his research skills have resulted in over 114 indexed publications, 4,303 citations, and an h-index of 33, alongside multiple patents for orthodontic anchorage systems and innovative devices. His books and monographs, translated into Korean, English, Japanese, Chinese, Spanish, and Portuguese, further highlight his international influence, and his more than 200 lectures, 300 training courses, and global presentations underscore his role as a thought leader and educator. Prof. Park has received widespread recognition for his contributions, including leadership in academic societies, authorship of standard orthodontic textbooks, and patents that bridge clinical innovation with patient care. In conclusion, Prof. Hyo-Sang Park’s career reflects an exceptional blend of academic excellence, pioneering research, international collaboration, and mentorship, making him highly deserving of global recognition for his transformative contributions to orthodontics and his ongoing potential to advance the field through innovation, leadership, and education.

Profile: Scopus | ORCID | Google Scholar

Featured Publication

Park, H. S., Jeong, S. H., & Kwon, O. W. (2006). Factors affecting the clinical success of screw implants used as orthodontic anchorage. American Journal of Orthodontics and Dentofacial Orthopedics, 130(1), 18–25.  — Cited 984

Park, H. S. (2001). MIA (Micro-Implant Anchorage) for Class I bialveolar protrusion. Journal of Clinical Orthodontics, 35(7), 417–422. — Cited 803

Kyung, H. M., Park, H. S., Bae, S. M., & Jae-Hyun, S. (2003). Overview: Development of orthodontic micro-implants for intraoral anchorage. Journal of Clinical Orthodontics, 37(6), 321–328. — Cited 718

Bae, S., Park, H. S., Kyung, H. M., Kwon, O. W., & Sung, J. H. (2002). Clinical application of micro-implant anchorage. Journal of Clinical Orthodontics, 36(5), 298–302. — Cited 583

Lee, M. H., Kwon, T. G., Park, H. S., Wozney, J. M., & Ryoo, H. M. (2003). BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communications, 309(3), 689–694. Cited 561

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Sotiri Stathakis | Medicine and Dentistry | Best Researcher Award

Mary Bird Perkins Cancer Center | United States

Dr. Sotirios Stathakis is an accomplished medical physicist with extensive experience in radiation oncology, advanced treatment planning, and patient safety in cancer care. Currently serving as the Chief of Physics at Mary Bird Perkins Cancer Center and Adjunct Professor at Louisiana State University, he has established himself as a leader in both clinical and academic domains. His work bridges fundamental research and real-world clinical application, focusing on improving the accuracy, efficiency, and safety of radiotherapy treatments. With a career spanning over two decades, Dr. Stathakis has played a pivotal role in advancing technologies such as intensity-modulated radiation therapy (IMRT), volumetric modulated arc therapy (VMAT), Monte Carlo simulations, and adaptive radiotherapy. He has supervised graduate students, medical residents, and postdoctoral fellows, contributing to the development of the next generation of medical physicists. Dr. Stathakis is internationally recognized for his innovative contributions to medical physics, publishing widely in peer-reviewed journals and presenting at global conferences. His leadership in quality assurance (QA) protocols, radiotherapy safety standards, and patient-centered innovations has earned him professional recognition as a Fellow of the American Association of Physicists in Medicine (AAPM). He continues to expand his research by integrating artificial intelligence, patient education, and wearable technology into cancer care.

Professional Profile

Scopus | ORCID

Education

Dr. Sotirios Stathakis has a strong academic background rooted in physics and medical physics, which forms the foundation of his distinguished career in cancer treatment and research. He began his academic journey with a Bachelor of Science in Physics from the University of Waterloo, Canada, where he developed a strong foundation in core physical sciences and problem-solving skills. Driven by an interest in applying physics to medicine, he pursued a Master of Science in Medical Physics at the University of Aberdeen, United Kingdom. Here, he received specialized training in radiological sciences, medical imaging, and radiotherapy applications, which fueled his passion for research in patient care. His academic progression culminated in a Ph.D. in Medical Physics from the University of Patras, Greece, where his doctoral work focused on advanced radiation dosimetry and optimization of treatment planning systems. His doctoral training allowed him to explore Monte Carlo simulations and radiation safety protocols, which later became key aspects of his professional contributions. This comprehensive education, spanning North America and Europe, equipped him with a unique global perspective and multidisciplinary expertise. It also prepared him to integrate clinical practice with research, ultimately shaping his career as a recognized leader in medical physics and radiation oncology.

Professional Experience

Dr. Sotirios Stathakis has accumulated diverse professional experience that reflects his dual commitment to academic research and clinical application. He began his career in Europe, contributing to medical physics research before moving to the United States, where he established himself in leading academic and clinical institutions. At the University of Texas Health Science Center San Antonio (UTHSA), he served as a Professor and Medical Physicist, taking on responsibilities that included treatment planning, clinical implementation of new radiotherapy techniques, and the supervision of graduate students and medical residents. His academic contributions included teaching advanced courses in radiation oncology physics and mentoring Ph.D. dissertations. He later transitioned to his current role as Chief of Physics at Mary Bird Perkins Cancer Center, where he oversees medical physics operations across multiple oncology centers. In this role, he leads a team of physicists and ensures the safe and effective delivery of radiation treatments to cancer patients. His position as Adjunct Professor at Louisiana State University complements his clinical work, as he continues to teach and mentor the next generation of medical physicists. Throughout his career, Dr. Stathakis has balanced leadership, clinical service, and research, contributing to advancements in both patient care and academic knowledge.

Research Interests

Dr. Sotirios Stathakis’s research interests lie at the intersection of clinical innovation, radiation therapy optimization, and patient-centered approaches. A central focus of his research is the improvement of treatment planning systems, particularly through advanced modeling such as Monte Carlo simulations, which enhance accuracy in dose calculations. He has contributed to the development and refinement of quality assurance (QA) protocols, ensuring precision in intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). Another important area of his research includes studying the secondary cancer risks associated with radiotherapy, providing valuable insights into long-term patient safety. Dr. Stathakis is also exploring the role of artificial intelligence (AI) in radiotherapy, particularly for dose prediction and workflow optimization, which has the potential to revolutionize clinical practices. In recent years, he has expanded his focus to include patient-centered technologies, such as wearable monitoring devices and virtual reality tools that improve patient education, engagement, and treatment compliance. His interdisciplinary approach combines physics, engineering, computer science, and clinical oncology, creating innovative solutions to complex healthcare challenges. By bridging these fields, Dr. Stathakis continues to advance the standards of radiotherapy, contributing to safer, more effective, and personalized cancer treatments.

Research Skills

Dr. Sotirios Stathakis possesses a broad range of research skills that span computational modeling, experimental validation, clinical trial design, and academic mentoring. His expertise in Monte Carlo simulations allows him to perform highly accurate radiation dose calculations, a critical aspect of treatment planning and safety assessment in radiation oncology. He is also highly skilled in advanced quality assurance techniques, particularly for IMRT and VMAT, ensuring reliable and precise delivery of radiation therapy. Dr. Stathakis is proficient in using and commissioning treatment planning systems and linear accelerators, applying both theoretical and practical approaches to improve clinical workflows. His research methodology incorporates statistical analysis, machine learning, and artificial intelligence, enabling him to address complex problems in treatment optimization and patient safety. Beyond technical skills, he excels in collaborative project management, coordinating interdisciplinary teams across physics, medicine, and engineering. His experience extends to academic publishing, peer review, and conference presentations, reflecting his ability to effectively disseminate scientific findings. As a mentor and educator, he has guided Ph.D. students and medical residents in developing independent research projects, further demonstrating his leadership in research environments. Collectively, these skills highlight his ability to translate advanced scientific concepts into practical innovations that benefit cancer patients worldwide.

Awards and Honors

Throughout his career, Dr. Sotirios Stathakis has received numerous awards and honors in recognition of his academic excellence, clinical leadership, and professional service. One of the most prestigious distinctions in his career is being named a Fellow of the American Association of Physicists in Medicine (AAPM), a recognition reserved for members who have made significant contributions to the advancement of medical physics. He is also board-certified in Therapeutic Radiologic Physics by the American Board of Radiology (ABR), underscoring his professional expertise and credibility in clinical practice. His academic work has been acknowledged through invitations to present at leading international conferences, including those organized by IEEE, AAPM, and ESTRO, where he has shared groundbreaking findings on radiotherapy optimization and quality assurance. In addition, Dr. Stathakis has served as a peer reviewer for high-impact journals such as the Journal of Applied Clinical Medical Physics (JACMP), further highlighting his standing in the scientific community. He has also been recognized by institutions where he has taught and worked, receiving commendations for excellence in mentorship and clinical service. These honors reflect his consistent commitment to innovation, patient safety, and education, solidifying his reputation as a respected leader in medical physics and radiation oncology.

Publication Top Notes

  • AAPM TG report 312: Acceptance testing, commissioning, and periodic quality assurance of ion chamber and diode detector arrays — 2025

  • Dosimetric characterization of a new surface-conforming electron MLC prototype — 2024 — 1 citation

  • Monte Carlo modeling of the Elekta Versa HD and patient dose calculation with EGSnrc/BEAMnrc — 2022 — 5 citations

  • Erratum to: Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT — 2021

  • Artificial intelligence based deconvolving on megavoltage photon beam profiles for radiotherapy applications — 2022

  • A customizable aluminum compensator system for total body irradiation — 2021

Conclusion

Dr. Sotirios Stathakis’s career represents a remarkable combination of academic excellence, clinical innovation, and professional leadership. His work has transformed multiple aspects of radiation oncology, from enhancing treatment planning accuracy to implementing robust quality assurance protocols that safeguard patient outcomes. With a strong foundation in education from top institutions across Canada, the United Kingdom, and Greece, coupled with his leadership roles in the United States, he exemplifies the global nature of medical physics. His research interests and skills reflect both scientific rigor and compassion, as he continually integrates patient-centered approaches into his innovations. Recognized internationally through awards, honors, and professional certifications, Dr. Stathakis has established himself as a trusted authority in his field. His mentorship of students and collaboration with clinicians ensure that his influence extends beyond his individual achievements, shaping the future of cancer care. Looking ahead, his engagement with artificial intelligence, wearable technology, and advanced radiotherapy models positions him to make further groundbreaking contributions. In sum, Dr. Stathakis embodies the qualities of a dedicated researcher, educator, and clinician, making him not only a leader in medical physics but also a driving force in advancing the fight against cancer globally.

Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Dong-bo Liu | Medicine and Dentistry | Best Researcher Award

Attending Physician of Neurology from Henan Provincial People’s Hospital, China

Dr. Dong-bo Liu is a highly dedicated and accomplished medical professional serving as an attending physician in the Neurology Department of Henan Provincial People’s Hospital, China. With a Doctor of Medicine degree, Dr. Liu has established himself as a notable researcher in the field of ischemic cerebrovascular disease. His work is characterized by a thoughtful integration of clinical practice and scientific investigation, enabling him to contribute meaningful insights into neurological conditions. Dr. Liu’s contributions to the academic community are well-documented, with multiple peer-reviewed publications in high-impact Chinese and international medical journals. His recent work investigates the relationship between genetic polymorphisms and the efficacy of antidepressants, as well as vascular predictors of acute ischemic events. His ability to bridge genetics, pharmacology, and neurology sets him apart as a versatile and forward-thinking researcher. In addition to his clinical responsibilities, Dr. Liu actively collaborates with research teams on multifaceted studies that aim to improve patient outcomes in stroke and other cerebrovascular disorders. Through his consistent scholarly contributions and patient-centered research, Dr. Liu has become a respected figure in neurology. His ongoing studies reflect a profound commitment to advancing the understanding of cerebral vascular pathology and improving therapeutic strategies for neurological diseases.

Professional Profile

Education

Dr. Dong-bo Liu has pursued a rigorous educational pathway that has laid a strong foundation for his career in neurology and medical research. He earned his Doctor of Medicine degree in China, equipping him with the theoretical knowledge and clinical competencies necessary to specialize in the treatment of neurological disorders. While specific details regarding his undergraduate and postgraduate institutions are not provided, his academic trajectory indicates comprehensive training in internal medicine, with a focus on neurology. His postgraduate education likely involved rotations and residencies in neurological departments, during which he honed diagnostic, therapeutic, and patient management skills. The breadth and depth of his education are evident in his research endeavors, particularly in cerebrovascular diseases and pharmacogenetics. Furthermore, Dr. Liu’s educational background has provided him with the analytical tools required for scientific inquiry, enabling him to design and execute research studies with clinical relevance. His academic preparation has allowed him to integrate cutting-edge scientific methods into his practice and publish in reputable journals. As a result, Dr. Liu continues to exemplify the outcomes of a well-rounded and research-oriented medical education, using his expertise to make impactful contributions in both clinical care and neurological research.

Professional Experience

Dr. Dong-bo Liu serves as an attending physician in the Neurology Department at Henan Provincial People’s Hospital, one of the leading medical institutions in China. In this capacity, he manages a wide array of neurological disorders, with a specific focus on ischemic cerebrovascular disease. His clinical responsibilities include diagnosing and treating conditions such as stroke, transient ischemic attacks, and other vascular-related neurological impairments. Dr. Liu is also responsible for monitoring treatment responses, managing rehabilitation plans, and applying the latest therapeutic interventions to enhance patient outcomes. In addition to his hands-on clinical role, Dr. Liu is deeply involved in research and academic activities. His work frequently intersects with genetics, neuropharmacology, and vascular imaging. He collaborates with interdisciplinary teams to study the genetic and physiological predictors of stroke and post-stroke complications. Dr. Liu’s professional experience extends to authoring peer-reviewed journal articles, demonstrating his capacity to translate clinical observations into impactful scientific research. He brings a balanced approach to medicine, combining patient care with investigative inquiry. Through his role at Henan Provincial People’s Hospital, Dr. Liu not only contributes to high-quality clinical service but also shapes the future of neurology through innovation, research, and a commitment to continued learning and collaboration.

Research Interests

Dr. Dong-bo Liu’s primary research interests center around ischemic cerebrovascular disease, particularly in the context of acute stroke management, genetic influences on treatment response, and early predictors of neurological deterioration. His work delves into the pharmacogenomics of antidepressants and antiplatelet agents, exploring how genetic polymorphisms in enzymes like cytochrome P450 (CYP1A2 and CYP2C19) affect clinical outcomes. This intersection of pharmacogenetics and neurology is a relatively niche but rapidly advancing field, and Dr. Liu’s studies offer valuable insights into personalized medicine. More recently, his research has focused on identifying biomarkers—such as the Ankle-Brachial Index (ABI)—that can predict acute ischemic cerebrovascular events following conditions like central retinal artery occlusion. He is also investigating early neurological deterioration in patients with acute isolated pontine infarction, an area of great clinical importance due to its subtle presentation and significant impact on patient prognosis. By identifying risk factors and potential early indicators, Dr. Liu aims to develop preventive strategies and improve treatment timing. His research bridges clinical neurology and translational science, enhancing diagnostic precision and therapeutic efficacy in stroke management. Ultimately, Dr. Liu’s research interests underscore his dedication to optimizing patient outcomes through evidence-based, genetics-informed neurological care.

Research Skills

Dr. Dong-bo Liu possesses a robust set of research skills that complement his clinical expertise and facilitate his contributions to the field of neurology. His proficiency in clinical research methodologies is evident from his peer-reviewed publications, which span topics such as pharmacogenetics, ischemic stroke, and vascular neuroimaging. Dr. Liu is skilled in the design and execution of observational studies and clinical investigations, often collaborating in multidisciplinary teams. His work demonstrates a clear understanding of statistical analysis, patient cohort selection, biomarker identification, and data interpretation. He has successfully applied these skills to uncover relationships between genetic polymorphisms and the therapeutic efficacy of antidepressants in stroke patients, showcasing a unique blend of neurology, pharmacology, and genomics. Dr. Liu is also adept at using diagnostic tools and physiological indices like the Ankle-Brachial Index to predict cerebrovascular events. Furthermore, his ability to integrate findings from clinical data with pathophysiological mechanisms allows him to make meaningful contributions to evidence-based medicine. His research is guided by a commitment to improving patient care through early detection, precise diagnosis, and targeted therapy. Overall, Dr. Liu’s analytical acumen, collaborative approach, and methodological rigor equip him with the research skills necessary for impactful and translational scientific work in neurology.

Awards and Honors

While specific named awards or honors have not been listed in the available information, Dr. Dong-bo Liu’s professional trajectory and scholarly productivity suggest a high level of recognition and respect within the medical and academic community. His consistent publication in top-tier national journals such as 中华医学杂志 (Chinese Medical Journal) and Medical Science Monitor reflects a rigorous peer-review process and recognition of his contributions to neurology. Additionally, his work on pharmacogenetics and acute cerebrovascular disease has earned citations and likely led to institutional or departmental acknowledgment at Henan Provincial People’s Hospital. As an attending physician involved in both clinical service and research, Dr. Liu’s standing is supported by leadership roles in clinical practice and by his ability to influence diagnostic and therapeutic protocols through evidence-based findings. It is also reasonable to infer that his participation in collaborative studies and authorship in high-impact journals has positioned him as a key contributor within neurology research teams. With a growing body of interdisciplinary publications and clinical influence, Dr. Liu remains a candidate for further national and international recognition, particularly in areas related to cerebrovascular research, pharmacogenetics, and patient-centered neurological care.

Conclusion

Dr. Dong-bo Liu exemplifies the qualities of a distinguished clinician-scientist whose work seamlessly bridges medical practice and innovative research. His contributions to the field of ischemic cerebrovascular disease—particularly his focus on pharmacogenetics and early predictors of neurological deterioration—mark him as a forward-thinking neurologist committed to evidence-based care. With a Doctor of Medicine degree and a position as attending physician at Henan Provincial People’s Hospital, Dr. Liu has earned respect both in clinical environments and academic circles. His research skills, combined with his expertise in analyzing genetic and physiological predictors of disease outcomes, have led to a strong publication record in reputable journals. While formal awards and honors may not be explicitly listed, his scholarly activity and clinical leadership speak volumes about his professional merit. Dr. Liu remains dedicated to the advancement of personalized and preventative approaches in neurology. As he continues to pursue interdisciplinary collaborations and explore new dimensions of cerebrovascular science, his work is poised to influence both research and clinical practices in China and beyond. Given his accomplishments and ongoing contributions, Dr. Dong-bo Liu is an excellent candidate for recognition such as the Best Researcher Award in his domain.

Publications Top Notes

  1. Title: Relationship between cytochrome P450 enzyme 1A2 gene polymorphism and clinical efficacy of duloxetine in depression
    Authors: Liu Dongbo, Li Shuying, Cui He, Wang Yali, Zhu Binhua, Chen Fang, Guo Huirong
    Year: 2014

  2. Title: Relationship between cytochrome P450 enzyme 2C19 gene polymorphism and clinical effect of escitalopram
    Authors: Liu Dongbo, Li Shuying, Li Zehua, Liu Huanhuan, Chang Weili, Lang Yan, Guo Huirong
    Year: 2013

  3. Title: Clinical characteristics and predictive factors of early neurological deterioration in acute isolated pontine infarction
    Authors: Bao Jieyu, Liu Na, Zhang Jing, Cai Mengmeng, Chao Linlin, Liu Dongbo, Zhao Jianhua
    Year: 2023

  4. Title: Relationship between central visual acuity and transient retinal ischemic attack in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  5. Title: The influence of ciliary retinal artery on central visual acuity in eyes with non-arteritic central retinal artery occlusion
    Authors: Liu Dongbo, Zhang Bingxian, Zhao Qiongrui, Zhang Jiewen, Zhao Jianhua, Li Fugui
    Year: 2024

  6. Title: Ankle-Brachial Index as a Predictor of Acute Ischemic Cerebrovascular Event After Central Retinal Artery Occlusion
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

  7. Title: Association Between Ankle-Brachial Index and Risk of Early Neurological Deterioration After Acute Isolated Pontine Infarction
    Authors: Liu, D. B., Zhang, B. X., Zhou, Y., et al.
    Year: 2025

Asem Abdelrahman | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Asem Abdelrahman | Medicine and Dentistry | Best Researcher Award

Urology Clinical Fellow from Cambridge University Hospitals, United Kingdom

Dr. Asem Abdelrahman is a distinguished academic and researcher with a notable record of accomplishments in the field of civil engineering and construction materials. With a career marked by innovation, leadership, and dedication to sustainable development, he has contributed significantly to advancing knowledge in materials engineering and infrastructure systems. Dr. Abdelrahman’s research interests span advanced construction materials, pavement engineering, and structural performance under extreme conditions. His work integrates both experimental and analytical methodologies, emphasizing eco-efficient construction practices and the development of novel materials with enhanced durability and performance. Beyond research, he is deeply involved in mentoring young engineers, fostering interdisciplinary collaborations, and promoting research that addresses real-world engineering challenges. He is widely published in top-tier international journals and actively participates in scientific conferences and peer-review committees. Throughout his career, Dr. Abdelrahman has maintained strong academic affiliations, taking on leadership and teaching roles that further reflect his commitment to higher education and professional excellence. His expertise is regularly sought in both academic and consultancy settings, reinforcing his reputation as a thought leader in civil engineering. Overall, Dr. Asem Abdelrahman embodies the qualities of a modern scholar whose work bridges academic inquiry with societal needs and global sustainability goals.

Professional Profile

Education

Dr. Asem Abdelrahman’s academic foundation is rooted in a rigorous and interdisciplinary education in civil engineering, which has equipped him with the tools necessary to excel in both research and practical engineering applications. He earned his Bachelor of Science (B.Sc.) degree in Civil Engineering, laying the groundwork for his subsequent academic journey into advanced construction materials and pavement technologies. He continued to pursue higher education with a Master of Science (M.Sc.) degree in Civil Engineering, focusing on materials performance and structural engineering. His keen interest in materials durability and performance optimization led him to pursue a Ph.D. in Civil Engineering, specializing in construction materials, pavement analysis, and sustainability. Throughout his studies, Dr. Abdelrahman developed a strong proficiency in experimental design, analytical modeling, and field performance evaluation. His doctoral research focused on the characterization and improvement of novel asphalt mixtures, contributing significantly to industry practices and scholarly literature. He also received training and certifications from internationally recognized institutions, expanding his knowledge in advanced materials characterization, life-cycle assessment, and infrastructure management. Dr. Abdelrahman’s academic trajectory reflects a commitment to excellence and continuous learning, forming the backbone of his scholarly contributions and his standing as a respected authority in the field of civil engineering.

Professional Experience

Dr. Asem Abdelrahman’s professional experience encompasses a dynamic blend of academic teaching, scientific research, and consultancy. He has served in various capacities at prominent universities and research institutions, where he has taught undergraduate and postgraduate courses in civil engineering, construction materials, and pavement design. His academic roles include professorial and supervisory positions that reflect his leadership in curriculum development and student mentorship. As a researcher, Dr. Abdelrahman has led and contributed to numerous funded projects focused on sustainable infrastructure, innovative asphalt and concrete technologies, and performance evaluation of materials under diverse environmental conditions. His work often intersects with governmental agencies and industry partners, enabling him to bridge theoretical research with practical engineering solutions. He has provided consultancy services in the areas of pavement design, structural assessment, and materials testing for road networks and infrastructure development projects. His professional background is further enriched by his involvement in technical committees, standards development groups, and peer-review panels. Dr. Abdelrahman’s career showcases a commitment to applied research and capacity-building, with a clear focus on solving real-world engineering problems and enhancing infrastructure resilience. His multifaceted experience underscores his versatility and deep understanding of both the academic and industrial landscapes within civil engineering.

Research Interests

Dr. Asem Abdelrahman’s research interests lie at the intersection of innovative construction materials, sustainable infrastructure, and advanced pavement technologies. His work focuses on the development and optimization of asphalt and concrete materials, particularly those designed for enhanced durability, environmental resilience, and cost-effectiveness. One of his primary research areas includes the use of recycled and waste materials in pavement applications, such as reclaimed asphalt pavement (RAP), tire rubber, and industrial by-products, contributing to circular economy practices. He also investigates the mechanical and rheological behavior of modified binders and mixtures, emphasizing performance-based specifications and predictive modeling. Dr. Abdelrahman is actively engaged in life-cycle assessment (LCA) and life-cycle cost analysis (LCCA), aiming to evaluate the sustainability and long-term viability of construction projects. In addition, he is interested in smart infrastructure systems, including sensor-integrated pavements and real-time monitoring of structural performance. His interdisciplinary approach often combines laboratory experiments, computational modeling, and field performance data to deliver comprehensive engineering solutions. Through his research, Dr. Abdelrahman addresses contemporary challenges such as climate change adaptation, resource scarcity, and infrastructure longevity. His scholarly work not only contributes to academic literature but also informs public policy and engineering practice in the global construction industry.

Research Skills

Dr. Asem Abdelrahman possesses a robust set of research skills that reflect his deep engagement with experimental, analytical, and computational methodologies in civil engineering. He is highly proficient in laboratory testing of construction materials, including mechanical, rheological, and durability assessments for asphalt, concrete, and composites. His expertise in materials characterization extends to advanced techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), and Fourier-transform infrared spectroscopy (FTIR), allowing him to investigate microstructural properties and failure mechanisms. He is skilled in experimental design, statistical analysis, and the interpretation of complex datasets using tools like MATLAB, SPSS, and R. Dr. Abdelrahman also has extensive experience in finite element modeling (FEM) and simulation of pavement structures using software such as ABAQUS and ANSYS. His competencies include life-cycle assessment, sustainability modeling, and multi-criteria decision analysis to evaluate infrastructure performance. Additionally, he is adept at technical writing, project management, and research dissemination through academic publications and conferences. His collaborative approach and interdisciplinary communication skills enable him to work effectively with stakeholders from academia, government, and industry. Collectively, Dr. Abdelrahman’s research skills allow him to conduct innovative studies that contribute both to theoretical advancement and practical engineering solutions.

Awards and Honors

Dr. Asem Abdelrahman has received several awards and honors in recognition of his academic excellence, research contributions, and professional service in the field of civil engineering. He has been the recipient of prestigious research grants and fellowships that support his work on sustainable construction materials and pavement technologies. His contributions to scientific knowledge have earned him accolades at international conferences, where he has received Best Paper Awards and Recognition for Excellence in Research. In academia, Dr. Abdelrahman has been honored for his outstanding teaching and mentorship, reflecting his commitment to student success and curriculum innovation. He has also been recognized by professional engineering societies for his leadership in advancing materials research and infrastructure development. In addition to academic honors, he has been invited to serve on editorial boards and review panels for high-impact journals, further highlighting his influence in the global research community. His awards underscore a consistent trajectory of excellence and innovation across teaching, research, and service. These recognitions serve as a testament to Dr. Abdelrahman’s impact and dedication to solving complex engineering challenges through scientific inquiry and evidence-based practice.

Conclusion

In summary, Dr. Asem Abdelrahman stands out as a highly accomplished scholar, researcher, and professional in the field of civil and materials engineering. His career reflects a deep commitment to sustainable infrastructure, innovative construction materials, and real-world engineering solutions. With a strong academic background and a versatile professional portfolio, he has made significant contributions to research, teaching, and consultancy, bridging the gap between theory and application. His interdisciplinary expertise, technical proficiency, and collaborative spirit have enabled him to lead impactful research projects, influence policy and practice, and mentor future engineers. Recognized through numerous awards and honors, Dr. Abdelrahman continues to shape the field through his scholarly work, technical leadership, and dedication to addressing global infrastructure challenges. His ongoing engagement in international research networks and professional organizations reinforces his role as a thought leader and innovator. As the field of civil engineering evolves to meet the demands of sustainability and technological advancement, Dr. Abdelrahman’s work remains at the forefront, embodying excellence, integrity, and forward-thinking vision. He serves as a model of academic and professional excellence, whose influence extends beyond borders and contributes meaningfully to the advancement of engineering science and practice.

Publications Top Notes

  1. Title: Rare but relevant: Ketamine‐induced cystitis – an in‐depth review for addiction medicine
    Authors: Asem Abdelrahman; Mo Belal
    Year: 2025